参考文献/References:
［参 考 文 献］
［1］ Siegel R, Ma J, Zou Z, et al. Cancer statistics, 2014［J］. CA Cancer J Clin, 2014, 64: 9- 29.
［2］ Fidias P, Novello S. Strategies for prolonged therapy in patients with advanced non- small- cell lung cancer［J］. J Clin Oncol, 2010, 28: 5116- 5123.
［3］ Whitehurst AW, Bodemann BO, Cardenas J, et al. Synthetic lethal screen identification of chemosensitizer loci in cancer cells［J］. Nature, 2007, 446: 815- 819.
［4］ Sachs RK, Chen AM, Brenner DJ. Review: proximity effects in the production of chromosome aberrations by ionizing radiation［J］. Int J Radiat Biol, 1997, 71: 1- 19.
［5］ Karakoyun- Celik O, Yalman D, Bolukbasi Y, et al. Postoperative radiotherapy in the management of resected non- small- cell lung carcinoma: 10 years’ experience in a single institute［J］. Int J Radiat Oncol Biol Phys, 2010, 76: 433- 439.
［6］ Lehnert S, Reniers B, Verhaegen F. Relative biologic effective- ness in terms of tumor response of 125I implants compared with 60Co gamma rays［J］. Int J Radiat Oncol Biol Phys, 2005, 63: 224- 229.
［7］ 骆红蕾， 喻晓娟， 李 进， 等． 125I粒子植入联合化疗治疗同期放化疗后局部复发的Ⅲ期非小细胞肺癌［J］． 中华核医学与分子影像杂志， 2013， 33： 195- 198．
［8］ 陆 健， 郑云峰， 张 欢， 等． CT导引下植入125I粒子治疗19例晚期胰腺癌的疗效观察［J］． 介入放射学杂志， 2010， 19： 550- 553．
［9］ 彭晶晶， 谭 勇， 谭 艳， 等． 125I粒子植入治疗结肠直肠癌肝转移［J］． 介入放射学杂志， 2012， 21： 773- 776．
［10］ Nishizaki M, Meyn RE, Levy LB, et al. Synergistic inhibition of human lung cancer cell growth by adenovirus- mediated wild- type p53 gene transfer in combination with docetaxel and radiation therapeutics in vitro and in vivo［J］. Clin Cancer Res, 2001, 7: 2887- 2897.
［11］ Chen H, Bao Y, Yu L, et al. Comparison of cellular damage response to low- dose- rate 125I seed irradiation and high- dose- rate gamma irradiation in human lung cancer cells［J］. Brachytherapy, 2012, 11: 149- 156.
［12］ Qu A, Wang H, Li J, et al. Biological effects of 125I seeds radiation on A549 lung cancer cells: G2/M arrest and enhanced cell death［J］. Cancer Invest, 2014, 32: 209- 217.
［13］ Iliakis G, Wang Y, Guan J, et al. DNA damage checkpoint control in cells exposed to ionizing radiation［J］. Oncogene, 2003, 22: 5834- 5847.
［14］ Kastan MB, Bartek J. Cell- cycle checkpoints and cancer［J］. Nature, 2004, 432: 316- 323.
［15］ Wang J, Wang J, Liao A, et al. The direct biologic effects of radioactive 125I seeds on pancreatic cancer cells PANC- 1, at continuous low- dose rates［J］. Cancer Biother Radiopharm, 2009, 24: 409- 416.
［16］ Liao A, Wang J, Wang J, et al. Relative biological effectiveness and cell- killing efficacy of continuous low- dose- rate 125I seeds on prostate carcinoma cells in vitro［J］. Integr Cancer Ther, 2010, 9: 59- 65.
［17］ Geyer RK, Nagasawa H, Little JB, et al. Role and regulation of p53 during an ultraviolet radiation- induced G1 cell cycle arrest［J］. Cell Growth Differ, 2000, 11: 149- 156.
［18］ Martinou JC, Youle RJ. Mitochondria in apoptosis: Bcl- 2 family members and mitochondrial dynamics［J］. Dev Cell, 2011, 21: 92- 101.
［19］ Ma JX, Jin ZD, Si PR, et al. Continuous and low- energy 125I seed irradiation changes DNA methyltransferases expression patterns and inhibits pancreatic cancer tumor growth［J］. J Exp Clin Cancer Res, 2011, 30: 35.
［20］ Groeger AM, Esposito V, De Luca A, et al. Prognostic value of immunohistochemical expression of p53, bax, Bcl- 2 and Bcl- xL in resected non- small- cell lung cancers［J］. Histopathology, 2004, 44: 54- 63.
［21］ Walensky LD. BCL- 2 in the crosshairs: tipping the balance of Life and death［J］. Cell Death Differ, 2006, 13: 1339- 1350.